---
document_datetime: 2025-06-10 12:33:32
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/qoyvolma-epar-all-authorised-presentations_en.pdf
document_name: qoyvolma-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3592786
conversion_datetime: 2025-12-26 09:47:18.94015
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## EMA Number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

EU/1/25/1925/001 Qoyvolma 45 mg Solution for injection Subcutaneous use pre-filled syringe (glass) 0.5 ml (90 mg/ml) 1 pre-filled syringe EU/1/25/1925/002 Qoyvolma 90 mg Solution for injection Subcutaneous use pre-filled syringe (glass) 1 ml (90 mg/ml) 1 pre-filled syringe EU/1/25/1925/003 Qoyvolma 130 mg Concentrate for solution for infusion Intravenous use vial (glass) 26 ml (5 mg/ml) 1 vial